Market Newsdesk

SAN JOSE, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) — Synaptics Incorporated (Nasdaq: SYNA), today announced its participation in four upcoming investor conferences.

• Jason Tsai, Head of Investor Relations, will be virtually attending the Wells Fargo 2020 TMT Summit on December 1, 2020.
• Michael Hurlston, President and CEO, will virtually present at the 24^th Annual Credit Suisse Technology Conference on December 2, 2020 at 4:50 p.m. EST. A live webcast of the presentation will be accessible by visiting Synaptics’ investor website at investor.synaptics.com.
• Dean Butler, CFO, will be virtually attending the Barclays Global Technology, Media and Telecommunications Conference on December 9, 2020.
• Dean Butler, CFO, will virtually present at the Needham Growth Conference 2021 on January 12, 2021 at 4:15 p.m. EST. A live webcast of the presentation will be accessible by visiting Synaptics’ investor website at investor.synaptics.com.

About Synaptics Incorporated

Synaptics (Nasdaq: SYNA) is pioneering the relationship between people and intelligent devices, bringing innovative and intuitive user experiences for the premium market. Synaptics’ broad portfolio of touch, display, biometrics, voice, video, vision, AI, audio and connectivity products are built on the company’s rich R&D, extensive IP and dependable supply chain capabilities. With solutions designed for the smart home, smartphones, PC and peripherals, and automotive markets, Synaptics combines ease of use, functionality and aesthetics to enable products that help make our digital lives more productive, secure and enjoyable. Follow Synaptics on LinkedIn,Twitter and Facebook, or visit synaptics.com.

For more information contact:
Jason Tsai
Head of Investor Relations
[email protected]

 

Partner to Distribute Safe-T’s ZoneZero™ SDP Solution, Which Allows Access to Applications and Services Only After Trust Has Been Verified

HERZLIYA, Israel, Dec. 01, 2020 (GLOBE NEWSWIRE) —  

Safe-T® Group Ltd.
(NASDAQ, TASE: SFET), a provider of Secure Access solutions for on-premise and hybrid cloud environments, and Systematika Distribution Srl (“Systematika”), one of the leading operating companies in the distribution of solutions for the Professional Information Technology market, has signed an agreement for the distribution of Safe-T’s ZoneZero^TM SDP in Italy.

Safe-T’s ZoneZero SDP solution is a valuable addition to any organization, enabling enterprises to provide secure and transparent access to internal applications, services, and data. Safe-T’s patented reverse-access technology eliminates the need to open incoming ports in the organization’s firewall, thereby delivering seamless, effective and secure processes with a true separation between the data plane and the control plane, all built on top of the existing network setups, thus not requiring costly and timely changes in infrastructure.

“With over 35 years as a leading distributor of advanced technology solutions, Systematika is a perfect match for our ZoneZero solutions,” said Avi Rubinstein, Safe-T’s Chief Business Officer. “The addition of Systematika, a high-value partner with an impressive customer base, to our channel network will enable us to expand the introduction of our solutions and further promote our game changing products in Italy.”

The ZoneZero SDP solution is part of Safe-T’s ZoneZero Perimeter Access Orchestration suite, which provides central management of all secure-access technologies and allows organizations to implement a valid Zero Trust Network Access (ZTNA) architecture beyond the perimeter.

“Safe-T’s solutions will enhance our existing product offerings and services in the key area of cybersecurity,” said Franco Puricelli, the Managing Director of Systematika. “Keeping organizations safe from attacks and data leakage by securing the access itself, is critical and crucial, and even more so in this pandemic scenario. Thanks to Safe-T’s solutions, we will be able to support our partners and their customers to accomplish this mission.”

About Systematika

Systematika has been for over 35 years one of the most important operating companies in the distribution of solutions for the Professional Information Technology market.

A real point of reference for ICT operators, Systematika places the accent on “high-tech” distribution: not only an offer of innovative and reliable technologies, but also a series of training services, pre-sales support, workshops, marketing initiatives, incentives and consultancy completely available to its partners.

The core business focused on software – from marketing to consulting, from training to specific support for partners – allows Systematika to acquire and offer valuable skills and high professionalism, without sacrificing the breadth of the offer.

Qualified and professional staff, operational consistency in the choice of Qualified IT Resellers, competence and special attention to the evolution of IT are the main strengths on which Systematika bases the relationship with the customer, guaranteeing reliability, continuity and growth. For more information, please visit, https://systematika.it/.

About Safe-T®

Safe-T Group Ltd. (Nasdaq, TASE: SFET) is a provider of Zero Trust Access solutions which mitigate attacks on enterprises’ business-critical services and sensitive data, while ensuring uninterrupted business continuity.

Safe-T’s cloud and on-premises solutions ensure that an organization’s access use cases, whether into the organization or from the organization out to the internet, are secured according to the “validate first, access later” philosophy of Zero Trust. This means that no one is trusted by default from inside or outside the network, and verification is required from everyone trying to gain access to resources on the network or in the cloud.

Safe-T’s wide range of access solutions reduce organizations’ attack surface and improve their ability to defend against modern cyberthreats. As an additional layer of security, our integrated business-grade global proxy solution cloud service enables smooth and efficient traffic flow, interruption-free service, unlimited concurrent connections, instant scaling and simple integration with our services.

With Safe-T’s patented reverse-access technology and proprietary routing technology, organizations of all size and type can secure their data, services and networks against internal and external threats.

At Safe-T, we empower enterprises to safely migrate to the cloud and enable digital transformation.

Safe-T’s solutions on AWS Marketplace is available here

For more information about Safe-T, visit www.safe-t.com

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Safe-T is using forward-looking statements in this press release when it discusses the advantages of its ZoneZero™ SDP solution, the potential of the relationship with Systematika Distribution Srl, the benefits of partnership between Safe-T and Systematika Distribution Srl to organizations in Italy and the potential of the ZoneZero™ SDP solution and/or the distribution agreement to address market need and/or demand in Italy. Because such statements deal with future events and are based on Safe-T’s current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of Safe-T could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Safe-T’s annual report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on March 31, 2020, and in any subsequent filings with the SEC. Except as otherwise required by law, Safe-T undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.

SAFE-T CONTACT:
Maya Meiri
M: +972(0)52 3259171
[email protected] 

SAN JOSE, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) — Broadcom Inc. (NASDAQ:AVGO) today announced the availability of the latest generation of AIOps from Broadcom, an open platform with artificial intelligence, machine learning and end-to-end observability that helps organizations achieve operational excellence. AIOps allows business and IT leaders to manage critical KPIs that align IT outputs to business outcomes, driving digital agility, while proactively ensuring enhanced customer and positive employee experiences.

“Imagine a lens that provides a clear and fully integrated view of your business with IT providing valuable intelligence that drives informed decision-making. This is no longer a wish list, this is a reality for our customers through the new Broadcom AIOps solution,” said Serge Lucio, vice president and general manager, Enterprise Software Division, Broadcom. “AIOps from Broadcom provides enterprises with comprehensive observability across user experience, applications, infrastructure and networks delivering digital agility, actionable insights and intelligent automation— all enhancing business outcomes and customer experience.”

As enterprises progress in their ongoing digital transformations, they face complex modern and hybrid IT environments, while adopting Site Reliability Engineering and automation approaches to achieve operational effectiveness. Customers and employees now demand instant access to services delivered by IT teams. However, many struggle to gain vital insights across heterogeneous digital landscapes due to disparate tooling, increased volume of data, increase in remote traffic, frequency in redundant tasks, and lack of actionable insights.

New
Leading-Edge
Capabilities

AIOps from Broadcom is an open platform that correlates and analyzes a broad range of IT observability data sources and acts as a trusted proof point for the IT Operations analytics offered in Broadcom’s BizOps solution. AIOps from Broadcom now includes new AI/ML techniques and customizable views for enhanced actionable insights. New capabilities include:

• Full-Stack
  Observability
  — for hybrid clouds, cloud-native applications, distributed tracing, mobile-to-mainframe insights and network telemetry while providing users openness to ingest other data sources quickly with 15 new third-party data integrations.

• DX Dashboards
  — provide rich visualizations for task-based persona-driven insights along with unfettered access to all data to easily customize and create company-specific dashboards.

• Service and
  Alarm Analytics
  — include additional machine learning topology and correlation, casual graphs and intelligent situational analysis for automatic root cause analysis, noise mitigation, alarm clustering, and anomaly detection.

• Intelligent Automation
  — based on a recommendation engine connects root cause analysis with extensive out-of-the-box actions and automation strategy based on problem scenarios.

• Capacity Analytics
  — provide service-aware configuration for capacity planning and drill-downs for service context and group context to identify the potential over-utilized or under-utilized resources and optimize the capacity allocation.

• Continuous Feedback Loops
  — connect data across development, IT and the business for views and insights across disparate data sets and siloed teams.

• Machine Learning
  — based on an extensive library of algorithms, natural language processing and an ontological graphical topology for rich situational correlation for continuous learning and improved automated root cause analysis.

• Software to Silicon
  Insights— apply AI and ML to rich, granular data capture at the chip level to enable a unique, AI-driven solution for real-time proactive network congestion and packet loss triage.

“It was vital that our teams moved from a focus on managing IT resources to managing business implementations, so we started by eliminating the lines that traditionally separated IT and business,” said Mike Sydor, chief architect, ADP. “A big part of that effort required us to establish views, dashboards, and reports that reflected both perspectives. By leveraging the comprehensive insights garnered through AIOps from Broadcom, we were able to accelerate the move away from having staff concentrate on individual metrics and instead have them focused on the metrics that are significant for good business outcomes.” ¹ [read the full story here]

Forrester recommends organizations invest in AIOps saying, “AI for IT operations (AIOps) is unifying traditional infrastructure, public cloud, application performance management (APM), and even network monitoring.” ² – Rich Lane, senior analyst, Forrester Research.

Broadcom AIOps Virtual Forum

In conjunction with this announcement, Broadcom unveiled the results of a Broadcom sponsored report “Using AIOps to Gain Observability and Insight: A Global Survey of Executives and IT Professionals” conducted by Dimensional Research. For a full copy of the report and to learn more about how the world’s leading companies are driving business outcomes, join Broadcom for the AIOps Virtual Forum, “Maximizing Value and Success with AIOps in 2021,” December 3, 2020 at 11AM (ET). Visit AIOps from Broadcom to learn more about how AIOps is augmenting human intelligence to help manage increasingly complex app infrastructures, automate remediation and align business and IT.

About Broadcom

Broadcom Inc. (NASDAQ: AVGO) is a global technology leader that designs, develops and supplies a broad range of semiconductor and infrastructure software solutions. Broadcom’s category-leading product portfolio serves critical markets including data center, networking, enterprise software, broadband, wireless, storage and industrial. Our solutions include data center networking and storage, enterprise, mainframe and cyber security software focused on automation, monitoring and security, smartphone components, telecoms and factory automation. For more information, go to www.broadcom.com.

Broadcom, the pulse logo, and Connecting everything are among the trademarks of Broadcom. The term “Broadcom” refers to Broadcom Inc., and/or its subsidiaries. Other trademarks are the property of their respective owners.

¹
How IT Transformation at ADP is Fueling Operational Excellence

²
The Forrester Tech Tide™: Modern Technology Operations, Q3 2020

Press Contact:
Jon Piazza
Broadcom Inc.
[email protected] 
310.498.5254

DENVER, Dec. 01, 2020 (GLOBE NEWSWIRE) — NewAge, Inc. (Nasdaq: NBEV), the Colorado-based social selling and distribution company with a network of independent business owners across 75 countries worldwide, today announced that it will close a new debt facility for a total of $30 million, increasing its unrestricted cash balance to more than $50 million.

The new two-year debt facility with funds and accounts managed by JGB Management, Inc. (JGB), replaces the existing line of credit that the Company had in place with East West Bank, which will be satisfied in full at closing. In addition to eliminating the East West facility, the new line of credit will be used to provide $10 million in cash as part of the ARIIX transaction and for general working capital purposes. Details of the agreement are included in the Company’s Current Report on Form 8-K filed on December 1, 2020.

Greg Gould, Chief Financial Officer of NewAge, commented, “We are pleased to be able to secure this financing and partner with a great organization like JGB. I’m excited about our new partnership with JGB, which even further strengthens our company’s financial position. We intend to use the funds to fully pay off our loan balance with East West Bank, fulfill our cash payment obligation under the ARIIX transaction, and use strategically to fund operating activities designed to accelerate our global organic revenue growth. With the addition of this financing our unrestricted cash balance will now exceed $50 million. With the completion of the NewAge/ARIIX merger and the expected improved cash generation of the combined company augmented with the new credit facility, I believe we have significant financial flexibility to meet our organic operating needs throughout 2021.”

Brett Cohen, Founder of JGB mentioned, “We are very excited to be working with NewAge and to provide the financing for their organic growth and other needs. We look forward to this new relationship and being a key component of their strategic growth plans.”

Advising NewAge on the transaction was A.G.P./Alliance Global Partners as advisor and placement agent. 

About


NewAge


, Inc.


(NASDAQ:


NBEV


)


NewAge is a Colorado-based organic and healthy products company intending to become one of the world’s leading social selling and distribution companies. The Company builds brands across three primary platforms including health and wellness, healthy appearance, and nutritional performance. NewAge employs an omnichannel route to market across more than 75 countries worldwide with a team of more than 400,000 independent distributors. The Company operates the websites newage.com, noninewage.com, ariix.com, mavie.com, thelimucompany.com, zennoa.com and a number of other individual brand websites.

About A.G.P. /Alliance Global Partners


A.G.P./Alliance Global Partners is an investment banking and advisory firm that has been a member of FINRA and registered with the SEC since 1980. A.G.P provides brokerage and wealth management services with access to all major domestic exchanges as well as over 30 global markets. A.G.P. specializes in wealth management and the middle market institutional arena. A.G.P. provides clients with boutique-level services along with the confidence of knowing their assets are held at Fidelity Clearing and Custody. A.G.P maintains long-lasting relationships with clients, ranging from some of the largest institutions investors and selected individual investors. More information on Alliance General Partners can be found at www.allianceg.com.

Safe Harbor Disclosure


This press release contains forward-looking statements that are made under the safe harbor provisions within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are any statement reflecting management’s expectations regarding future results of operations, economic performance, financial condition, the acquisition of ARIIX, statements about the benefit of the ARIIX transaction, upgrades to NewAge’s financial position, acceleration of our global organic revenue growth, expected improved cash generation of the combined company, having significant financial flexibility to meet the Company’s organic operating needs throughout 2021, and the extent and duration of COVID-19 on its business. The forward-looking statements are based on the assumption that operating performance and results will continue in line with historical results. Management believes these assumptions to be reasonable, but there is no assurance they will prove to be accurate. Forward-looking statements, specifically those concerning future performance, are subject to certain risks and uncertainties, and actual results may differ materially. NewAge competes in a rapidly growing and transforming industry, and risk factors, including those disclosed in the Company’s filings with the Securities and Exchange Commission, might affect the Company’s operations. Unless required by applicable law, the Company undertakes no obligation to update or revise any forward-looking statements.

For investor inquiries about NewAge please contact:

NewAge
Investor Relations:

Riley Timmer
Vice President, Investor Relations
Tel: 1-801-870-8685
[email protected]

Investor Relations Counsel:

John Mills/Scott Van Winkle
ICR – Strategic Communications and Advisory
Tel: 1-646-277-1254/1-617-956-6736
[email protected]

NewAge
, Inc.
:

Gregory A. Gould
Chief Financial Officer
Tel: 1-303-566-3030
[email protected]

MANCHESTER, Conn., Dec. 01, 2020 (GLOBE NEWSWIRE) — Lydall, Inc. (NYSE: LDL) announced today that it will host its Lydall Investor Day 2020 event virtually on Wednesday, December 9, 2020.

Lydall’s leadership team will unveil the Company’s strategic roadmap to deliver long-term shareholder value, including capital allocation strategy and financial targets. A video invitation from President and Chief Executive Officer Sara Greenstein can be viewed here: https://www.youtube.com/watch?v=9nRImRYLIDI&feature=youtu.be

The presentation will begin at 10:00am Eastern Time, to be immediately followed by a question and answer session. The Company’s statements may contain or constitute material information that has not been previously disclosed. The event will be hosted by:

• Sara A. Greenstein, President and Chief Executive Officer;
• Randall B. Gonzales, Executive Vice President and Chief Financial Officer; and
• Ashish Diwanji, President, Lydall Performance Materials.

To access and register for this event, please go to Lydall’s Investor Relations page (https://ir.lydall.com), or click on the following link: https://primetime.bluejeans.com/a2m/register/xffprpvc

A live webcast and audio archive of the presentation will be available via the Investor Relations section of the company’s Web site at https://ir.lydall.com. Participants should allow approximately five to ten minutes prior to the presentation’s start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the company’s website for 90 days.

Headquartered in Manchester, Connecticut with global manufacturing operations, Lydall delivers value-added engineered materials and specialty filtration solutions that promote a cleaner, safer and quieter world. We partner with our customers to develop bespoke, high-performing and efficient solutions that are adaptable and scalable to meet their needs. Lydall is a New York Stock Exchange-listed company. For more information, visit http://www.lydall.com. Lydall is a registered trademark of Lydall, Inc. in the U.S. and other countries.  

For further information contact:
Media:
Danielle Orsino
Telephone 949-365-6609
[email protected]

Investors

Brendan Moynihan
Vice President, Investor Relations
Telephone 860-646-1233
Facsimile 860-646-8847
www.lydall.com
[email protected]

Washington, DC, Dec. 01, 2020 (GLOBE NEWSWIRE) — URAC, one of the nation’s oldest and most prestigious accrediting organizations announced today that they have developed a special accreditation offering for small-to-medium sized health plans, with a focus on affordability while still adhering to the highest standards in health care quality. These smaller health plans face particular challenges, especially in the current health care landscape and URAC aims to address some of these challenges with its new accreditation offering. URAC aims to reduce the financial barrier to entry so that smaller health plans earn recognition for their quality improvement activities, position themselves and demonstrate their value in caring for their membership, delivering the highest outcomes. URAC accreditation helps to improve the quality of health care delivered by health plans of all sizes. URAC knows that accreditation can help improve health care quality. Because health plans, like much of the health care ecosystem, have faced challenges throughout the pandemic, URAC made the decision to reduce the price of their accreditation to ensure that cost is not a barrier to improving health outcomes for health plan members. Recognizing that health plans of all sizes can benefit from a URAC Accreditation and that purchasing this accreditation has been challenging for smaller plans, URAC has established a new pricing structure for small health plans seeking accreditation that offers greater affordability than they have offered in the past. “These times are particularly difficult and health care is an especially challenging industry to work through,” said Shawn Griffin, MD, URAC’s President and CEO. “Health plans are facing some fundamental unknowns that can make it difficult to make longer-term plans.” URAC aims to be part of the solution for health care quality in this uncertain time and beyond. “We want to help health plans make decisions to improve quality, and knowing that we can make the accreditation decision easier for smaller health plans by offering this new lower pricing, we are happy to do so,” added Griffin. URAC stands with its clients and other health care organizations during the pandemic and its aftermath. —————————————– About URAC Celebrating its 30th anniversary in 2020, URAC is the independent leader in promoting health care quality through leadership, accreditation, measurement and innovation. URAC is a non-profit organization that uses evidence-based measures and develops standards through inclusive engagement with a range of stakeholders who are committed to improving the quality of health care. Its portfolio of accreditation and certification programs span the health care industry, addressing health care management and operations, health plans, pharmacies, telehealth providers, physician practices, and more. URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality.

Attachment

• GettyImages-1061437154

Laura Wood, Director
URAC
202-326-3968
[email protected]

Prospective study published in Journal of the American Academy of Dermatology

BOCA RATON, Dec. 01, 2020 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the publication of a prospective clinical study showing that a single low dose of superficial radiation therapy (SRT) following excision of 14 keloids had an approximate 6.25% recurrence rate at six months, and for the 10 patients available for follow-up at 24 months none of the keloids had recurred.

The study was published in the Journal of the American Academy of Dermatology and can be found here. Lead authors were Yuna Son, M.S., Ernest Owen Nicandro Phillips B.S. and Kristin Magrini Price, M.D., all of the Department of Biomedical Sciences and Division of Dermatology, Florida State University College of Medicine.

A total of 15 black patients with 20 untreated keloids in various anatomic locations were recruited for the study to undergo surgical excision followed by a single dose of superficial radiation. The authors concluded that a single 8 Gy dose of superficial 50 kV radiation delivered an average of 34 days after keloid excision may be sufficient to minimize recurrence, including in individuals who are resistant to steroids. The authors noted that higher radiation energies, doses or fractions may be unnecessary for keloid therapy.

“Although this was a small study, the outcome is important,” said Joe Sardano, chief executive officer of Sensus Healthcare. “The investigators noted that there are few prospective studies with SRT following keloidectomy, and that the doses of SRT studied have not been standardized. This study shows that just one low dose of SRT can be impactful.  Not only does this minimize radiation exposure to the patient, but it also is cost effective. 

“We are delighted that the dermatology community is becoming increasingly aware of the role of SRT in treating disfiguring keloids. The publication of this study comes on the heels of a retrospective study published in the Journal of Clinical and Aesthetic Dermatology showing keloidectomy followed by SRT had an approximate 10% recurrence rate, compared with an expected recurrence rate of more than 80% following surgical excision alone,” Mr. Sardano added.

About Sensus Healthcare

Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions. The Sculptura™ modulated robotic brachytherapy radiation oncology system provides targeted directional anisotropic radiation therapy (ART) and brachytherapy utilizing our proprietary, state-of-the-art 3D Beam Sculpting™ to treat patients undergoing cancer treatment during surgery, or at the tumor site, fast and efficiently. Sensus also offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its portfolio of innovative medical device products, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world.

For more information, visit www.sensushealthcare.com.

Forward-Looking Statements

This press release includes statements that are, or may be deemed, ”forward-looking statements.” In some cases these forward-looking statements can be identified by the use of forward-looking terminology including “believes,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” “approximately,” “potential” or, in each case, their negative or other variations thereon or comparable terminology, although not all forward-looking statements contain these words.

By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics and healthcare, regulatory and scientific developments, and depend on the economic circumstances that may or may not occur in the future or may occur on longer or shorter timelines than anticipated. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and the development of the industry in which we operate may differ materially from the forward looking statements contained in this press release, as a result of, among other factors: the continuation and severity of the COVID-19 pandemic, including its impact on sales and marketing; our ability to achieve and sustain profitability; market acceptance of our product lines; our ability to successfully commercialize our products; our ability to compete effectively in selling our products and services, including responding to technological change and cost containment efforts of our customers; our need and ability to obtain additional financing in the future; our ability to expand, manage and maintain our direct sales and marketing organizations; our ability to obtain and maintain intellectual property of sufficient scope to adequately protect our products, and our ability to avoid infringing or otherwise violating the intellectual property rights of third parties; the willingness of healthcare providers to purchase our products if coverage, reimbursement and pricing from third party payors for procedures using our products declines; the level and availability of government and third party payor reimbursement for clinical procedures using our products; our ability to effectively manage our anticipated growth, including hiring and retaining qualified personnel; the regulatory requirements applicable to us and our competitors; our ability to manufacture our products to meet demand; our current reliance on third party manufacturers and sole- or single-source suppliers, as well as our ability to successfully transition manufacturing of our products in-house; our ability to reduce the per unit manufacturing costs; our ability to efficiently manage our manufacturing processes; the regulatory and legal risks, and certain operating risks, that our international operations subject us to; the fact that product quality issues or product defects may harm our business; the accuracy of our financial statements and accounting estimates, including allowances for accounts receivable and inventory obsolescence; any product liability claims; new legislation, administrative rules, or executive orders, including those that impact taxes and international trade regulation; concentration of our customers in the U.S. and China, including the concentration of sales to one particular customer in the U.S.; and other risks described from time to time in Sensus Healthcare’s filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

In addition, even if our results of operations, financial condition and liquidity, and the development of the industry in which we operate are consistent with the forward-looking statements contained in this press release, they may not be predictive of results or developments in future periods. Any forward-looking statements that we make in this press release speak only as of the date of such statement, and we undertake no obligation to update such statements to reflect events or circumstances after the date of this press release. You should read carefully our “Cautionary Note Regarding Forward-Looking Information” and the factors described in the “Risk Factors” section of our periodic reports filed with the Securities and Exchange Commission to better understand the risks and uncertainties inherent in our business.

Contact:


LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
[email protected]

SUNNYVALE, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) — Infinera (NASDAQ: INFN) announced today that SSE Enterprise Telecoms, one of the UK’s leading connectivity providers, has selected Infinera’s XTM Series for the second phase of its UK-wide network expansion. The expanded network will bring high-capacity services to more businesses across the UK, further facilitating 5G rollouts, and aiding in the deployment of next-generation connectivity technologies such as the Industrial Internet of Things (IIoT).

With Infinera’s XTM Series, SSE Enterprise Telecoms leverages an industry-leading optical solution optimized for 5G transport with high-performance synchronization capabilities and low latency. The network’s Layer 2 packet optical aggregation features also provide enterprise customers with high-bandwidth connectivity services over the same network. These benefits extend across SSE Enterprise Telecoms’ network, which upon completion will span over 30,000 km, delivering the high-speed, performance, and reach required to support the growing digital needs of UK organizations.

“This network expansion with Infinera’s XTM Series is key to our UK initiative as it enables new technologies including the IIoT and autonomous vehicles, as well as opening the door to new business technologies such as seamless, instant video streaming and immersive virtual and augmented reality,” said Dave Eddy, COO, SSE Enterprise Telecoms. “Infinera’s XTM solution provided the high performance, scalability, and flexibility required to meet our network needs.”

“The UK market’s bandwidth is growing exponentially, and SSE Enterprise Telecoms is poised to meet this growing demand as it more than doubles its number of connected exchanges,” said Nick Walden, Senior Vice President, Sales at Infinera. “We are proud to be a part of SSE Enterprise Telecoms’ network expansion as it ushers the era of 5G with the unique capabilities of Infinera’s XTM.”

Infinera Contacts:

Media:

Anna Vue
Tel. +1 (916) 595-8157
[email protected]

Investors:

Amitabh Passi
Head of Investor Relations
[email protected]

About SSE Enterprise Telecoms

SSE Enterprise Telecoms provides class-leading connectivity and data centre services that deliver very high performance, cost efficiency and a competitive edge. The company operates a 20,000+km private telecoms network and an estate of 90 commercial data centres that span the UK. With its extensive telecoms and data centre operational expertise it offers commercial security with unrivalled in-house engineering resource.

About Infinera

Infinera is a global supplier of innovative networking solutions that enable carriers, cloud operators, governments, and enterprises to scale network bandwidth, accelerate service innovation, and automate network operations. The Infinera end-to-end packet optical portfolio delivers industry-leading economics and performance in long-haul, submarine, data center interconnect, and metro transport applications. To learn more about Infinera, visit www.infinera.com, follow us on Twitter @Infinera, and read our latest blog posts at www.infinera.com/blog.

Infinera and the Infinera logo are registered trademarks of Infinera Corporation.

This press release contains forward-looking statements. These statements are not guarantees of results and should not be considered as an indication of future activity or future performance. Actual results may vary materially from these expectations as a result of various risks and uncertainties. Information about these risks and uncertainties, and other risks and uncertainties that affect Infinera’s business, is contained in the risk factors section and other sections of Infinera’s Quarterly Report on Form 10-Q for the Fiscal Quarter ended September 26, 2020 as filed with the SEC on November 5, 2020, as well as any subsequent reports filed with or furnished to the SEC. These reports are available on Infinera’s website at www.infinera.com and the SEC’s website at www.sec.gov. Infinera assumes no obligation to, and does not currently intend to, update any such forward-looking statements.

PALM BEACH GARDENS, Fla., Dec. 01, 2020 (GLOBE NEWSWIRE) — Integrity Implants Inc., a privately held medical device company dedicated to delivering innovative solutions for spine surgery, today announced the publication of another in a series of recent clinical articles in the International Journal of Spine Surgery (www.ijssurgery.com) highlighting its FlareHawk^® expandable interbody cage. In their paper, Clinical and Radiographic Outcomes After Minimally Invasive Transforaminal Lumbar Interbody Fusion (MIS TLIF) – Early Experience Using a Biplanar Expandable Cage for Lumbar Spondylolisthesis (International Journal of Spine Surgery October 2020, 7125; DOI: https://doi.org/10.14444/7125), Lee A. Tan, Joshua Rivera, Xiao A. Tan, Vivian P. Le, Larry T. Khoo, and Sigurd H. Berven demonstrate favorable vertebral body slip or spondylolisthesis reduction accompanied by an increase in segmental lordosis and positive patient-reported outcomes.

The retrospective review of 13 patients treated during a one-year period found a mean slippage reduction of 6.0mm along with an improvement in segmental lordosis, increases in foraminal and posterior disc height, as well as improvement in all radiographic parameters postoperatively. Patient-reported outcome measures including VAS back, VAS leg, and EQ5D also improved across the board. There were no findings of endplate violation, cage subsidence, or cage migration, and there were no reoperations or implant-related complications.

Lee Tan, M.D., Assistant Professor of Neurological Surgery at UCSF Medical Center in San Francisco, California, shares, “My early experience shows good short-term radiographic and clinical outcomes, with almost complete reduction of spondylolisthesis postoperatively in all cases. The absence of nerve root injury is suggestive that the biplanar expandable cage is safe and obviates the need for excessive nerve root retraction during cage insertion.”

As discussed in the article, one possible explanation for the clinical success is that the expansion of the cage in the horizontal plane increases surface area contact with the endplates to better distribute the load and reduce stress, while the multi-material cage design consisting of a titanium shim inserted into a PEEK shell allows the cage to contour to the patient’s endplates, further reducing the risk of endplate violation.

Sigurd Berven, M.D., Professor in Residence, Department of Orthopaedic Surgery at the University of California at San Francisco, adds, “A challenging aspect of the MIS TLIF procedure is inserting the cage through a relatively small surgical corridor with protection of the neural elements. Additionally, in a lordotic disc space, the posterior disc height is typically shorter than the anterior disc height, thus limiting the size of cage that can be inserted posteriorly, potentially limiting the amount of lordosis restoration. In these cases that often present with a collapsed disc space and bone-on-bone pathology, the low-profile, biplanar, and lordotically expanding FlareHawk cage is ideal for reducing risk to the neural elements on insertion of the implant, and for improving the surface area of the implant with the endplate and the restoration of segmental lordosis. After insertion, the cage and prepared disc space can be filled with allograft or autograft to optimize fusion. The results of the study are encouraging regarding the efficacy of MIS fusion using the technique.”

Dr. Tan concludes, “Remarkably, we had no cases of endplate violation or cage subsidence in this cohort. This is significantly lower than the rates reported in the current literature, which range from 6% up to 33%. I believe that the biplanar expansion is key to decreasing the likelihood of subsidence.”

The FlareHawk spinal implant is the flagship product for Integrity Implants and represents the first of its kind in the expandable cage market. Much like coronary stents that offer patients a less-invasive alternative to open-heart procedures, the FlareHawk expandable cage features a PEEK shell that is inserted in a compressed form that can be effectively passed through small neural pathways, and, once within the intervertebral disc space, expanded to a larger footprint and height. An open-architecture titanium shim inserted within the PEEK shell produces the expansion and creates a solid-state construct that is resistant to collapse yet has shown the ability to conform to endplate anatomy to increase surface contact area and lower stresses. The Adaptive Geometry™ and advanced multi-material composition embodied in the FlareHawk device respect patient anatomy both during insertion and for long-term stability. To date, over 8,500 FlareHawk cages have been implanted in more than 6,000 patients.

Chris Walsh, Integrity Implants CEO, adds, “Last month, we shared the encouraging results of a multi-center study highlighting the favorable fusion efficacy and endplate conforming geometry of the FlareHawk cage. This work by surgeons Lee Tan, Sig Berven, and Larry Khoo represents the third peer-reviewed study of the FlareHawk cage this year. Beyond intrinsic cage design and performance, the study addresses a specific pathology solution that resonates with surgeons. It is encouraging to see published literature echo surgeon confidence in the FlareHawk cage, and documenting the application of Adaptive Geometry to the important and increasingly popular MIS TLIF approach is yet another step in confirming our technology as a compelling clinical choice for surgeons.”

About FlareHawk Expandable Lumbar Interbody Fusion System

The FlareHawk Interbody Fusion System is indicated for spinal intervertebral body fusion with autogenous bone graft and/or allogeneic bone graft composed of cancellous and/or corticocancellous bone in skeletally mature individuals with degenerative disc disease (DDD) at one or two contiguous levels from L2 to S1, following discectomy. DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. These patients should have at least six (6) months of non-operative treatment. Additionally, these patients may have up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s). FlareHawk system spacers are intended to be used with supplemental fixation instrumentation, which has been cleared for use in the lumbar spine.

About Integrity Implants Inc.

Integrity Implants, founded in 2016 by seasoned business partners and spine leaders Chris Walsh and Wyatt Geist, is a privately held medical device company headquartered in Palm Beach Gardens, Florida. The Company is dedicated to delivering innovative spine products and solutions to surgeons and their patients around the globe. Its proprietary Adaptive Geometry™ technology fundamentally respects a patient’s neural, vascular, bony, and soft tissue anatomy, both during and after implantation.

For more information, please visit the Company’s website at www.integrityimplants.com.

Media Contact:

Mark Richards
512-913-9572
[email protected]

THE WOODLANDS, Texas, Dec. 01, 2020 (GLOBE NEWSWIRE) — Conn’s, Inc. (NASDAQ: CONN), a specialty retailer of furniture and mattresses, home appliances, consumer electronics, home office products and provider of consumer credit, today announced it will host a conference call on December 8, 2020 to discuss its third quarter fiscal year 2021 financial results. The conference call will begin at 10:00 A.M. CT (11:00 A.M. ET). A press release regarding the operating results will be released the same day before the market opens.

Participants can join the call by dialing 877-451-6152 or 201-389-0879. The conference call will also be broadcast simultaneously via webcast on a listen-only basis. A link to the earnings release and webcast will be available at ir.conns.com.

About Conn’s, Inc.

Conn’s HomePlus is a specialty retailer currently operating 140+ retail locations in Alabama, Arizona, Colorado, Florida, Georgia, Louisiana, Mississippi, Nevada, New Mexico, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, and Virginia.

The Company’s primary product categories include:

• Furniture and mattress, including furniture and related accessories for the living room, dining room and bedroom, as well as traditional and specialty mattresses;
• Home appliance, including refrigerators, freezers, washers, dryers, dishwashers and ranges;
• Consumer electronics, including LED, OLED, QLED, Ultra HD, and internet-ready televisions, gaming consoles, home theater and portable audio equipment; and
• Home office, including computers, printers and accessories.

Additionally, Conn’s HomePlus offers a variety of products on a seasonal basis. Unlike many of its competitors, Conn’s HomePlus provides flexible in-house credit options for its customers in addition to third-party financing programs and third-party lease-to-own payment plans.

CONN-G
Investor Contact:
S.M. Berger & Company
Andrew Berger, (216) 464-6400